Literature DB >> 25079051

Phosphodiesterase from Vipera lebetina venom - structure and characterization.

Katrin Trummal1, Anu Aaspõllu1, Külli Tõnismägi1, Mari Samel1, Juhan Subbi1, Jüri Siigur1, Ene Siigur2.   

Abstract

Nucleases and phosphatases are ubiquitous but mostly marginal components of snake venoms. These proteins have been studied quite extensively but up to now no data regarding their amino acid sequences confirmed at protein level have been published. The present study deals with purification, characterization, and structural properties of a phosphodiesterase from Vipera lebetina venom (VLPDE). The VLPDE with molecular mass of about 120 kDa hydrolyses ADP but not ATP and 5'-AMP. The aggregation of platelets induced by ADP or collagen is dose-dependently inhibited by VLPDE. The cloning and sequencing of the VLPDE-encoding cDNA resulted in 2772-nt sequence with ORF of 2556 nt. The translated sequence comprises 851 amino acids including the 23-amino acid signal peptide. VLPDE is synthesized as a 828-amino acid single-chain protein but subsequently cleaved to form a two-chain protein held together with disulfide bonds. In reducing conditions the enzyme behaves like a heterodimeric protein but, differently from the real heterodimers, it is synthesized as a single-chain protein. VLPDE is the first snake venom phosphodiesterase with established and confirmed primary structure.
Copyright © 2014 Elsevier B.V. and Société française de biochimie et biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  MALDI-TOF MS; Phosphodiesterase; Snake venom; Vipera lebetina; cDNA cloning

Mesh:

Substances:

Year:  2014        PMID: 25079051     DOI: 10.1016/j.biochi.2014.07.020

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

1.  Proteomic Deep Mining the Venom of the Red-Headed Krait, Bungarus flaviceps.

Authors:  Alex Chapeaurouge; Andreza Silva; Paulo Carvalho; Ryan J R McCleary; Cassandra Marie Modahl; Jonas Perales; R Manjunatha Kini; Stephen P Mackessy
Journal:  Toxins (Basel)       Date:  2018-09-13       Impact factor: 4.546

Review 2.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

3.  Potent In Vitro Phosphodiesterase 1 Inhibition of Flavone Isolated from Pistacia integerrima Galls.

Authors:  Abdur Rauf; Sami Bawazeer; Jesús Herrera-Bravo; Muslim Raza; Humaira Naz; Somia Gul; Naveed Muhammad; Zainab M Almarhoon; Yahia N Mabkhot; Mohamed Fawzy Ramadan; William N Setzer; Sevgi Durna Daştan; Shafi Mahmud; Javad Sharifi-Rad
Journal:  Biomed Res Int       Date:  2022-01-17       Impact factor: 3.411

Review 4.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

5.  The Sequence and a Three-Dimensional Structural Analysis Reveal Substrate Specificity Among Snake Venom Phosphodiesterases.

Authors:  Anwar Ullah; Kifayat Ullah; Hamid Ali; Christian Betzel; Shafiq Ur Rehman
Journal:  Toxins (Basel)       Date:  2019-10-28       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.